A pharmaceutical company in Morrisville has secured a deal worth up to nearly $650 million to license its multiple sclerosis treatment outside of North America.
A pharmaceutical company in Morrisville has secured a deal worth up to nearly $650 million to license its multiple sclerosis treatment outside of North America.
